Wells Fargo’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-118,085
| Closed | -$472K | – | 7260 |
|
|
2019
Q4 | $472K | Sell |
118,085
-7,001
| -6% | -$32.9K | ﹤0.01% | 4424 |
|
|
2019
Q3 | $613K | Buy |
125,086
+35,737
| +40% | +$200K | ﹤0.01% | 4228 |
|
|
2019
Q2 | $544K | Sell |
89,349
-65,852
| -42% | -$350K | ﹤0.01% | 4328 |
|
|
2019
Q1 | $901K | Buy |
155,201
+57,343
| +59% | +$592K | ﹤0.01% | 3956 |
|
|
2018
Q4 | $1.32M | Buy |
97,858
+2,237
| +2% | +$37.7K | ﹤0.01% | 3630 |
|
|
2018
Q3 | $1.86M | Buy |
95,621
+6,898
| +8% | +$147K | ﹤0.01% | 3469 |
|
|
2018
Q2 | $2.27M | Buy |
88,723
+9,064
| +11% | +$211K | ﹤0.01% | 3368 |
|
|
2018
Q1 | $1.6M | Sell |
79,659
-10,445
| -12% | -$244K | ﹤0.01% | 3548 |
|
|
2017
Q4 | $1.81M | Buy |
90,104
+18,743
| +26% | +$369K | ﹤0.01% | 3443 |
|
|
2017
Q3 | $1.48M | Buy |
71,361
+19,373
| +37% | +$328K | ﹤0.01% | 3548 |
|
|
2017
Q2 | $770K | Sell |
51,988
-13,296
| -20% | -$222K | ﹤0.01% | 3923 |
|
|
2017
Q1 | $1.04M | Sell |
65,284
-23,789
| -27% | -$343K | ﹤0.01% | 3722 |
|
|
2016
Q4 | $1.12M | Sell |
89,073
-2,404,445
| -96% | -$44.8M | ﹤0.01% | 3614 |
|
|
2016
Q3 | $69.8M | Buy |
2,493,518
+54,413
| +2% | +$1.83M | 0.03% | 642 |
|
|
2016
Q2 | $85.4M | Sell |
2,439,105
-146,821
| -6% | -$4.62M | 0.03% | 529 |
|
|
2016
Q1 | $70.9M | Buy |
2,585,926
+806,377
| +45% | +$23.7M | 0.03% | 596 |
|
|
2015
Q4 | $60.9M | Buy |
1,779,549
+1,301,025
| +272% | +$40.6M | 0.02% | 667 |
|
|
2015
Q3 | $13.7M | Sell |
478,524
-43,749
| -8% | -$1.87M | 0.01% | 1558 |
|
|
2015
Q2 | $23.4M | Buy |
522,273
+50,786
| +11% | +$1.91M | 0.01% | 1279 |
|
|
2015
Q1 | $16.3M | Buy |
471,487
+212,713
| +82% | +$5.79M | 0.01% | 1472 |
|
|
2014
Q4 | $7.08M | Buy |
+258,774
| New | +$6.28M | ﹤0.01% | 2075 |
|
Other funds holding DPLO
Wells Fargo's DPLO Position: Q1 2020 in Review
Wells Fargo sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 118,085 shares — an estimated $472K sold.
Wells Fargo first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $85.4M in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Wells Fargo reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Wells Fargo sold 118,085 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $472K.
- Wells Fargo first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Wells Fargo's DIPLOMAT PHARMACY, INC. position peaked at $85.4M in Q2 2016.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.